TNFRSF9 and peripheral arterial disease: Furthermore, following activation with SARS-CoV-2 spike protein, a significant increase in CD4+CD69+ (p < 0.01) and CD8+CD137 (p = 0.001) was observed in the PAD group as compared with the HC.